FTSE All-Share
4.472,12
PKT
-0,33
PKT
-0,01
%
Werbung
Analysen zu FTSE All-Share-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 05.11.24 | AstraZeneca Buy | Goldman Sachs Group Inc. | |
| 05.11.24 | AstraZeneca Sell | UBS AG | |
| 04.11.24 | Unilever Halten | DZ BANK | |
| 04.11.24 | Shell (ex Royal Dutch Shell) Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 04.11.24 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 01.11.24 | Shell (ex Royal Dutch Shell) Neutral | UBS AG | |
| 01.11.24 | Shell (ex Royal Dutch Shell) Buy | Goldman Sachs Group Inc. | |
| 01.11.24 | GSK Neutral | Goldman Sachs Group Inc. | |
| 01.11.24 | Shell (ex Royal Dutch Shell) Overweight | JP Morgan Chase & Co. | |
| 31.10.24 | Glencore Buy | Deutsche Bank AG | |
| 31.10.24 | Unilever Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 31.10.24 | GSK Buy | Deutsche Bank AG | |
| 31.10.24 | Glencore Buy | Goldman Sachs Group Inc. | |
| 31.10.24 | Shell (ex Royal Dutch Shell) Neutral | UBS AG | |
| 31.10.24 | GSK Neutral | UBS AG | |
| 31.10.24 | Shell (ex Royal Dutch Shell) Buy | Jefferies & Company Inc. | |
| 31.10.24 | Shell (ex Royal Dutch Shell) Outperform | RBC Capital Markets | |
| 31.10.24 | GSK Underweight | JP Morgan Chase & Co. | |
| 30.10.24 | GSK Neutral | Goldman Sachs Group Inc. | |
| 30.10.24 | BP Buy | UBS AG | |
| 30.10.24 | GSK Neutral | UBS AG | |
| 30.10.24 | HSBC Buy | Deutsche Bank AG | |
| 30.10.24 | London Stock Exchange (LSE) Hold | Deutsche Bank AG | |
| 30.10.24 | GSK Outperform | Bernstein Research | |
| 30.10.24 | GSK Underweight | JP Morgan Chase & Co. | |
| 30.10.24 | Glencore Outperform | RBC Capital Markets | |
| 30.10.24 | HSBC Neutral | UBS AG | |
| 30.10.24 | BP Sector Perform | RBC Capital Markets | |
| 29.10.24 | BP Underweight | JP Morgan Chase & Co. | |
| 29.10.24 | BP Halten | DZ BANK | |
| 29.10.24 | BP Sector Perform | RBC Capital Markets | |
| 29.10.24 | BP Buy | UBS AG | |
| 29.10.24 | HSBC Sector Perform | RBC Capital Markets | |
| 29.10.24 | HSBC Neutral | UBS AG | |
| 29.10.24 | HSBC Neutral | JP Morgan Chase & Co. | |
| 28.10.24 | Unilever Overweight | Barclays Capital | |
| 25.10.24 | London Stock Exchange (LSE) Outperform | RBC Capital Markets | |
| 25.10.24 | GSK Underweight | JP Morgan Chase & Co. | |
| 25.10.24 | Vodafone Group Buy | Deutsche Bank AG | |
| 25.10.24 | AstraZeneca Overweight | JP Morgan Chase & Co. |